EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Characterizing Granulocytopenia Associated with Thiamazole in Patients with Hyperthyroidism Based on Real‐World Data from the MID‐NET in Japan

Yuki Kinoshita, Kazuhiro Kajiyama iD, Chieko Ishiguro, Takahiro Nonaka iD, Ryota Kimura, Yuki Kikuchi, Naoya Horiuchi, Toyotaka Iguchi, Yoshiaki Uyama iD

Clinical Pharmacology & Therapeutics · 2023

DOI: 10.1002/cpt.2850 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, 2023. Verfasst von Yuki Kinoshita und 8 weiteren Autor:innen. Beteiligte Einrichtung: Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan. Hauptthemen laut MEDLINE: Hyperthyroidism, Agranulocytosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the requirement of routine blood tests during thiamazole treatment in Japan, granulocytopenia among patients treated with thiamazole has been occasionally reported to the Pharmaceuticals and Medical Devices Agency (PMDA). To characterize granulocytopenia in patients with thiamazole in Japan, the effects of routine blood tests were examined in a cohort of new users of thiamazole or propylthiouracil utilizing the MID‐NET. The occurrence of granulocytopenia (neutrophil count ≤ 1,500/μL) in a given period was compared between patients with and without blood test results prior to the period. The trend in neutrophil count during thiamazole treatment was also compared between patients with and without granulocytopenia. A nested case–control study based on the cohort was conducted to identify potential risk factors for granulocytopenia during thiamazole treatment. In the new user cohort including 4,371 patients treated with thiamazole, the occurrence of granulocytopenia in patients who had undergone blood tests at all previous periods was similar or higher than that among those who had not undergone blood test in all previous periods (e.g., adjusted odds ratio in period 2 was 1.63). The neutrophil count was relatively lower in the group of patients with granulocytopenia even before the occurrence of granulocytopenia. In a nested case–control study, an upward tendency of the risk was observed when a patient was co‐prescribed anti‐arrhythmic drugs or antiulcer drugs with thiamazole. The characteristics of granulocytopenia during thiamazole treatment elucidated in this study should be recognized in clinical practice for the proper use of thiamazole.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperthyroidismAgranulocytosisHumansMethimazoleAntithyroid AgentsCase-Control StudiesJapan

Substanzen

MethimazoleAntithyroid Agents

Autor:innen und Institutionen

  • Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Office of Pharmacovigilance I, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Office of Pharmacovigilance II, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.

ORCID-Profile: Kazuhiro Kajiyama, Takahiro Nonaka, Yoshiaki Uyama

Zitieren

APA

Kinoshita, Y., Kajiyama, K., Ishiguro, C., Nonaka, T., Kimura, R., Kikuchi, Y., Horiuchi, N., Iguchi, T., & Uyama, Y. (2023). Characterizing Granulocytopenia Associated with Thiamazole in Patients with Hyperthyroidism Based on Real‐World Data from the MID‐NET in Japan. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.2850

Vancouver

Kinoshita Y, Kajiyama K, Ishiguro C, Nonaka T, Kimura R, Kikuchi Y, et al. Characterizing Granulocytopenia Associated with Thiamazole in Patients with Hyperthyroidism Based on Real‐World Data from the MID‐NET in Japan. Clinical Pharmacology & Therapeutics. 2023. doi:10.1002/cpt.2850

BibTeX
@article{Kinoshita2023,
  author = {Kinoshita, Yuki and Kajiyama, Kazuhiro and Ishiguro, Chieko and Nonaka, Takahiro and Kimura, Ryota and Kikuchi, Yuki and Horiuchi, Naoya and Iguchi, Toyotaka and Uyama, Yoshiaki},
  title = {Characterizing Granulocytopenia Associated with Thiamazole in Patients with Hyperthyroidism Based on Real‐World Data from the MID‐NET in Japan},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2023},
  doi = {10.1002/cpt.2850}
}
Kostenlos starten →